New hope for older myeloma patients: trial tests 'On-Demand' drug strategy
NCT ID NCT05272826
Summary
This study is testing a combination of four drugs to control multiple myeloma in older adults who are not eligible for a stem cell transplant. The treatment plan is flexible—a fourth drug is added only if a patient's initial response isn't deep enough. The goal is to see how well this approach works and how safe it is for 75 participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hôpital Maisonneuve-Rosemont
RECRUITINGMontreal, Quebec, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
London Health Sciences Centre
RECRUITINGLondon, Ontario, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
McGill University Health Centre
RECRUITINGMontreal, Quebec, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Princess Margaret Hospital
RECRUITINGToronto, Ontario, Canada
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
QEII Health Science Centre
RECRUITINGHalifax, Nova Scotia, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.